Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN272201700078C
IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541712 |
| PSC | AN81 — AIDS RESEARCH - BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS AWARD FEE |
| Obligations | $329.8M |
| Current contract value | $329.8M |
| Potential contract value / ceiling | $332.4M |
| Start date | Aug 14, 2017 |
| Current end date | Aug 14, 2024 |
| Potential end date | Aug 15, 2024 |
| Latest award activity | Sep 8, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 32 of 32 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 8, 2025 | P00031 | $-9.8M | NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) |
| Aug 29, 2024 | P00030 | $-23.6M | TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS |
| Jul 8, 2024 | P00029 | $-26.0K | TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS |
| Jul 25, 2023 | P00028 | $9.7M | TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS |
| Jan 24, 2023 | P00027 | $-60.4K | TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS |
| Dec 20, 2022 | P00026 | $-150.8M | TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS |
| Aug 9, 2022 | P00025 | $9.5M | TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS |
| Jun 15, 2022 | P00024 | $0 | TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS |
| Apr 21, 2022 | P00023 | $653.1K | "COVID 19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH |
| Feb 28, 2022 | P00022 | $3.5M | "COVID 19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH |
| Feb 24, 2022 | P00021 | $-3.5M | "COVID 19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH |
| Oct 13, 2021 | P00020 | $0 | EO14042 TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS |
| Sep 24, 2021 | P00019 | $-269.9K | "COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH |
| Aug 11, 2021 | P00018 | $291.5M | "COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. ALSO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH |
| Jul 15, 2021 | P00017 | $-36.2M | "COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. |
| May 26, 2021 | P00016 | $-1.1M | "COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. |
| Apr 9, 2021 | P00015 | $131.5M | "COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL. |
| Jan 15, 2021 | P00014 | $0 | THE PURPOSE OF THIS CONTRACT IS TO CONTINUE TO PROVIDE A BROAD RANGE OF RESEARCH SUPPORT SERVICES TO THE CURRENT AND EVOLVING DAIDS SUPPORTED RESEARCH PORTFOLIO. |
| Dec 7, 2020 | P00013 | $8.9M | "COVID 19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL, AN OPERATION WARP SPEED PROJECT. |
| Dec 4, 2020 | P00012 | $-8.9M | "COVID -19": TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL, AN OPERATION WARP SPEED PROJECT. |
| Jul 28, 2020 | P00011 | $68.8M | "COVID-19" TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL, AN OPERATION WARP SPEED PROJECT. |
| Jul 27, 2020 | P00010 | $9.2M | PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR DAIDS-SUPPORTED CLINICAL RESEARCH PROGRAMS AND PROJECTS AS WELL OTHER INFECTIOUS DISEASES THAT ARE OF RELEVANCE TO HIV INFECTIOUS AND AT RISK POPULATIONS. OPTIONS TO I |
| Jul 10, 2020 | P00009 | $3.6M | "COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL, AN OPERATION WARP SPEED PROJECT. |
| Jun 25, 2020 | P00008 | $627.8K | "COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR NIAID/DAIDS-SUPPORTED CLINICAL RESEARCH PORTFOLIO AND OTHER INFECTIOUS DISEASES THAT ARE OF RELEVANCE TO HIV INFECTION AND AT RISK POPULATIONS. |
| Sep 19, 2019 | P00007 | $0 | R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH) |
| Jun 14, 2019 | P00006 | $9.0M | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) |
| Apr 18, 2019 | P00005 | $0 | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) |
| Jul 24, 2018 | 4 | $-603.4K | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) |
| Jun 25, 2018 | 3 | $8.8M | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) |
| May 4, 2018 | 2 | $373.4K | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) |
| Jan 29, 2018 | 1 | $230.0K | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) |
| Aug 14, 2017 | 0 | $8.6M | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.